cas 881674-56-2|| where to buy 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde

製品名:5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde

IUPAC Name:5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde

包装単位	有効在庫	価格（USD）
CM198689-25g	in stock	ƥƛ
CM198689-100g	in stock	ǫȯŞ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 881674-56-2 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:881674-56-2; 分子式:C11H8FNO; 融点:-; SMILESコード:O=CC1=CNC(C2=CC=CC=C2F)=C1; 密度:

: カタログ番号:CM198689; 分子量:189.19; 沸点:370.6±32.0°C at 760 mmHg; MDL番号:MFCD11875867; 保管方法:Keep in a tight container and store at 2°C~8°C

: Pyrroles; Pyrrole is a five membered heterocyclic compound with the molecular formula of C4H5N. Pyrrole has a ring composed of four carbon atoms and one nitrogen atom. Pyrrole is easy to polymerize in the air. Pyrrole is the parent compound of many important biological substances (such as bile pigment, porphyrin and chlorophyll). Pyrrole scaffolds are widely used in biological and pharmaceutical fields. Pyrrole is a special heterocyclic scaffold, which exists in many natural products, drug molecules and pesticides, and has shown its application in materials science.; Pyrrole,Where to Buy Pyrroles-Chemenu; Pyrrole,Where to Buy Pyrroles; Pyrrole is a heterocyclic, aromatic, organic compound, a five-membered ring with the formula C 4H 4NH. It is a colorless volatile liquid that darkens readily upon exposure to air. Substituted derivatives are also called pyrroles, e.g., N-methylpyrrole.

: Vonoprazan; Nov. 01, 2023, FDA has approved VOQUEZNA (vonoprazan) tablets, a novel potassium-competitive acid blocker (PCAB), as a new treatment for adults for the healing of all grades of Erosive Esophagitis, also known as Erosive GERD (gastroesophageal reflux disease).
PCABs are a novel class of medicines that block acid secretion in the stomach, and VOQUEZNA is the first PCAB to be approved in the U.S. Vonoprazan has shown the potential to provide acid suppression that can achieve pH levels that are important in enhancing treatment effectiveness.